Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0%
Mon, 4 Feb

DR. REDDYS LAB has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

DR. REDDYS LAB Quarterly Financials

No. of Mths
Qtr. Ending
QoQ ChangeYoY Change
Net SalesRs m38,34138,17538,6461.2%0.8%
Other incomeRs m4301,2821,023-20.2%137.9%
TurnoverRs m38,77139,45739,6690.5%2.3%
ExpensesRs m30,41430,58230,6000.1%0.6%
Gross profitRs m7,9277,5938,0466.0%1.5%
DepreciationRs m2,7152,7862,9034.2%6.9%
InterestRs m17220824115.9%40.1%
Profit before taxRs m5,4705,8815,9250.7%8.3%
TaxRs m2,5288071,01125.3%-60.0%
Profit after taxRs m2,9425,0744,914-3.2%67.0%
Gross profit margin%20.719.920.8
Effective tax rate%46.213.717.1
Net profit margin%7.612.912.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster

Year-on-Year Performance:
  • The company's operating income during the quarter grew 0.8% on a year-on-year (YoY) basis. The expenses were up by 0.6% YoY during the same period.
  • The company's operating profit increased by 1.5% YoY during the quarter. Consequently, operating profit margins remained same and stood at 20.8% in 3QFY19.
  • Depreciation charges increased by 6.9% and finance costs increased by 40.1% YoY, respectively.
  • Other income increased by 137.9% YoY during the quarter.
  • Net profit for the quarter increased by 67.0% YoY. Net profit margins during the quarter increased from 7.6% in 3QFY18 to 12.4% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 1.2% on a quarter-on-quarter (QoQ) basis. The expenses were up by 0.1% QoQ during the same period.
  • The company's operating profit increased by 6.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 20.8% in 3QFY19 as against 19.9% in 2QFY18.
  • Net profit for the quarter declined by 3.2% QoQ, while net profit margins declined from 12.9% in 2QFY18 to 12.4% in 3QFY19.

To see how DR. REDDYS LAB has performed over the last eight quarters, please visit here.

DR. REDDYS LAB Share Price Performance

Over the last one year, DR. REDDYS LAB share price has moved up from Rs 2,122.1 to Rs 2,756.0, registering a Gain of Rs 633.9 or around 29.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,823.0 (down 1.2%). Over the last one year it has moved down from 14,067.6 to 13,823.0, a gain of 245 points (down 1.7%).

Overall, the S&P BSE SENSEX is up 1.5% over the year.

Current Valuations

At the current price of Rs 2,756.0, the price to earnings (P/E) ratio of DR. REDDYS LAB stands at 26.1 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.6 times.

Equitymaster requests your view! Post a comment on "DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0%". Click here!


Related Views on News

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...


Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms


Apr 25, 2019 (Close)


  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks